Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings

Benzinga

10/01

AngioDynamics, Inc. (NASDAQ:ANGO) will release earnings results for the first quarter, before the opening bell on Thursday, Oct. 2.

Analysts expect the Latham, New York-based company to report a quarterly loss at 12 cents per share, versus a year-ago loss of 11 cents per share in the year-ago period. AngioDynamics projects to report quarterly revenue at $72.69 million, compared to $67.49 million a year earlier, according to data from Benzinga Pro.

On July 15, AngioDynamics reported better-than-expected fourth-quarter financial results and issued FY26 revenue guidance above estimates.

Shares of AngioDynamics rose 4% to close at $11.17 on Tuesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

HC Wainwright & Co. analyst Yi Chen reiterated a Buy rating with a price target of $16 on July 16, 2025. This analyst has an accuracy rate of 64%.
Canaccord Genuity analyst William Plovanic maintained a Buy rating and boosted the price target from $15 to $17 on July 16, 2025. This analyst has an accuracy rate of 57%.

Considering buying ANGO stock? Here’s what analysts think:

Read This Next:

Top 2 Energy Stocks You May Want To Dump This Month

Photo via Shutterstock

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2572553245"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2572553245\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2572553245?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-01 21:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572553245","market":"hk","top_or_hot":-1,"title":"Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings","media":"Benzinga","content":"<html><body><p><strong>AngioDynamics, Inc.</strong> (NASDAQ:ANGO) will release earnings results for the first quarter, before the opening bell on Thursday, Oct. 2.</p>\n<p>Analysts expect the Latham, New York-based company to report a quarterly loss at 12 cents per share, versus a year-ago loss of 11 cents per share in the year-ago period. AngioDynamics projects to report quarterly revenue at $72.69 million, compared to $67.49 million a year earlier, according to data from Benzinga Pro.</p>\n<p>On July 15, AngioDynamics reported better-than-expected fourth-quarter financial results and issued FY26 revenue guidance above estimates.</p>\n<p>Shares of AngioDynamics rose 4% to close at $11.17 on Tuesday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>HC Wainwright &amp; Co. analyst Yi Chen reiterated a Buy rating with a price target of $16 on July 16, 2025. This analyst has an accuracy rate of 64%.</li>\n<li><a href=\"https://laohu8.com/S/CCORF\">Canaccord Genuity</a> analyst William Plovanic maintained a Buy rating and boosted the price target from $15 to $17 on July 16, 2025. This analyst has an accuracy rate of 57%.</li>\n</ul>\n<p>Considering buying ANGO stock? Here’s what analysts think:</p>\n<p><strong>Read This Next:</strong></p>\n<ul>\n<li><strong> Top 2 Energy Stocks You May Want To Dump This Month</strong></li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2025-10-01 21:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong>AngioDynamics, Inc.</strong> (NASDAQ:ANGO) will release earnings results for the first quarter, before the opening bell on Thursday, Oct. 2.</p>\n<p>Analysts expect the Latham, New York-based company to report a quarterly loss at 12 cents per share, versus a year-ago loss of 11 cents per share in the year-ago period. AngioDynamics projects to report quarterly revenue at $72.69 million, compared to $67.49 million a year earlier, according to data from Benzinga Pro.</p>\n<p>On July 15, AngioDynamics reported better-than-expected fourth-quarter financial results and issued FY26 revenue guidance above estimates.</p>\n<p>Shares of AngioDynamics rose 4% to close at $11.17 on Tuesday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>HC Wainwright &amp; Co. analyst Yi Chen reiterated a Buy rating with a price target of $16 on July 16, 2025. This analyst has an accuracy rate of 64%.</li>\n<li><a href=\"https://laohu8.com/S/CCORF\">Canaccord Genuity</a> analyst William Plovanic maintained a Buy rating and boosted the price target from $15 to $17 on July 16, 2025. This analyst has an accuracy rate of 57%.</li>\n</ul>\n<p>Considering buying ANGO stock? Here’s what analysts think:</p>\n<p><strong>Read This Next:</strong></p>\n<ul>\n<li><strong> Top 2 Energy Stocks You May Want To Dump This Month</strong></li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ANGO","symbol_name":"Angiodynamics","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/25/10/47968672/top-wall-street-forecasters-revamp-angiodynamics-expectations-ahead-of-q1-earnings","article_id":"2572553245","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572553245","pubTimestamp":1759327077,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ANGO":"Angiodynamics"},"translate_title":"华尔街顶级预测者在第一季度盈利前修改了血管动力学预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ANGO":1.5},"content_text":"AngioDynamics, Inc. (NASDAQ:ANGO) will release earnings results for the first quarter, before the opening bell on Thursday, Oct. 2.\nAnalysts expect the Latham, New York-based company to report a quarterly loss at 12 cents per share, versus a year-ago loss of 11 cents per share in the year-ago period. AngioDynamics projects to report quarterly revenue at $72.69 million, compared to $67.49 million a year earlier, according to data from Benzinga Pro.\nOn July 15, AngioDynamics reported better-than-expected fourth-quarter financial results and issued FY26 revenue guidance above estimates.\nShares of AngioDynamics rose 4% to close at $11.17 on Tuesday.\nBenzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.\nLet's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.\n\nHC Wainwright & Co. analyst Yi Chen reiterated a Buy rating with a price target of $16 on July 16, 2025. This analyst has an accuracy rate of 64%.\nCanaccord Genuity analyst William Plovanic maintained a Buy rating and boosted the price target from $15 to $17 on July 16, 2025. This analyst has an accuracy rate of 57%.\n\nConsidering buying ANGO stock? Here’s what analysts think:\nRead This Next:\n\n Top 2 Energy Stocks You May Want To Dump This Month\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}